CA2382426A1 - Melange pharmaceutique d'ethinylestradiol et de drospirenone utilise en tant que contraceptif - Google Patents

Melange pharmaceutique d'ethinylestradiol et de drospirenone utilise en tant que contraceptif Download PDF

Info

Publication number
CA2382426A1
CA2382426A1 CA002382426A CA2382426A CA2382426A1 CA 2382426 A1 CA2382426 A1 CA 2382426A1 CA 002382426 A CA002382426 A CA 002382426A CA 2382426 A CA2382426 A CA 2382426A CA 2382426 A1 CA2382426 A1 CA 2382426A1
Authority
CA
Canada
Prior art keywords
ethinylestradiol
daily dosage
beta
drospirenone
active agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002382426A
Other languages
English (en)
Other versions
CA2382426C (fr
Inventor
Wolfgang Heil
Jurgen Hilman
Ralph Lipp
Renate Heithecker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26153358&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2382426(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Priority claimed from PCT/IB2000/001213 external-priority patent/WO2001015701A1/fr
Publication of CA2382426A1 publication Critical patent/CA2382426A1/fr
Application granted granted Critical
Publication of CA2382426C publication Critical patent/CA2382426C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA002382426A 1999-08-31 2000-08-31 Melange pharmaceutique d'ethinylestradiol et de drospirenone utilise en tant que contraceptif Expired - Lifetime CA2382426C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24095399P 1999-08-31 1999-08-31
EP99202826 1999-08-31
US60/240,953 1999-08-31
EP99202826.6 1999-08-31
PCT/IB2000/001213 WO2001015701A1 (fr) 1999-08-31 2000-08-31 Melange pharmaceutique d'ethinylestradiol et de drospirenone utilise en tant que contraceptif

Publications (2)

Publication Number Publication Date
CA2382426A1 true CA2382426A1 (fr) 2001-03-08
CA2382426C CA2382426C (fr) 2006-02-28

Family

ID=26153358

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002382426A Expired - Lifetime CA2382426C (fr) 1999-08-31 2000-08-31 Melange pharmaceutique d'ethinylestradiol et de drospirenone utilise en tant que contraceptif

Country Status (11)

Country Link
CN (1) CN1223350C (fr)
BG (2) BG109749A (fr)
CA (1) CA2382426C (fr)
EE (1) EE05317B1 (fr)
HR (1) HRP20020258B1 (fr)
IL (2) IL197396A (fr)
MX (1) MXPA02002043A (fr)
NO (3) NO327588B3 (fr)
RU (4) RU2269342C2 (fr)
SK (1) SK287634B6 (fr)
UA (1) UA81387C2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1625849A1 (fr) * 2004-08-09 2006-02-15 Liconsa, Liberacion Controlada de Sustancias Activas, S.A. Composition pharmaceutique contenant ethinylestradiol et drospirenone
CN101489563A (zh) * 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 用于避孕和预防先天性畸形风险的药物制剂
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US8633178B2 (en) 2011-11-23 2014-01-21 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
RU2618471C2 (ru) * 2012-12-03 2017-05-03 Закрытое Акционерное Общество "Вертекс" Пероральная фармацевтическая композиция диуретика и ингибитора АПФ в микронизированной форме, лекарственное средство и его применение
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
EP3145489A1 (fr) 2014-05-22 2017-03-29 TherapeuticsMD, Inc. Formulations d'hormones substitutives combinées naturelles et traitement hormonal substitutif
CN108606963B (zh) * 2017-12-27 2021-05-18 上海长海医院 含有屈螺酮和雌激素的复方避孕贴、制备方法及应用
CN111529482A (zh) * 2020-05-20 2020-08-14 祝培 十一酸睾酮缓释植入剂及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) * 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE4411585A1 (de) * 1994-03-30 1995-10-05 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE69729956T2 (de) * 1996-07-26 2004-12-16 Wyeth Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält

Also Published As

Publication number Publication date
NO20083854L (no) 2002-04-26
HRP20020258B1 (hr) 2007-05-31
RU2269342C2 (ru) 2006-02-10
IL197396A (en) 2010-04-29
IL200482A0 (en) 2011-07-31
BG65204B1 (bg) 2007-07-31
RU2005131868A (ru) 2007-04-20
RU2449796C2 (ru) 2006-02-10
RU2396082C2 (ru) 2010-08-10
RU2269342C9 (ru) 2007-10-27
NO327588B3 (no) 2011-05-16
NO20091809L (no) 2002-04-26
CN1407895A (zh) 2003-04-02
MXPA02002043A (es) 2003-08-20
EE05317B1 (et) 2010-08-16
NO2010004I1 (no) 2010-03-22
SK2572002A3 (en) 2002-11-06
SK287634B6 (sk) 2011-04-05
CN1223350C (zh) 2005-10-19
BG106533A (bg) 2002-10-31
HRP20020258A2 (en) 2005-02-28
NO327588B1 (no) 2009-08-31
RU2482853C2 (ru) 2013-05-27
RU2010114825A (ru) 2011-10-20
EE200900049A (et) 2009-10-15
BG109749A (bg) 2008-06-30
CA2382426C (fr) 2006-02-28
UA81387C2 (en) 2008-01-10
RU2449796C9 (ru) 2007-10-27

Similar Documents

Publication Publication Date Title
YU14502A (sh) Farmaceutska kombinacija etinilestradiola i drospirenona za primenu kao kontraceptivnog sredstva
BG66095B1 (bg) Хидрофилен състав с контролирано освобождаване съдържащ прежелатинирано нишесте в препарат
UA41401C2 (uk) Фармацевтичний контрацептивний комбінований препарат
CA2131350A1 (fr) Formulation medicamenteuse a liberation continue contenant un sel tramadol
CA2240329A1 (fr) Administration amelioree de doses multiples de medicaments
NO327588B1 (no) Farmasoytisk sammensetning og preparat omfattende etinylostradiol og drospirenon for anvendelse som antikonsepsjonsmiddel
TW355683B (en) Composition containing micronized nebivolol
WO2000018447A3 (fr) Systeme multiplexe de liberation de medicaments approprie a l'administration par voie orale
IE831799L (en) Controlled release naproxen and naproxen sodium tablets.
RU99101114A (ru) Схемы приема прогестогена-антипрогестогена
AU9018898A (en) Phosphazole-containing nucleoside analogs, related compounds, pharmaceutical compositions thereof, and their use in in vitro medicinal treatments
WO1994002103A3 (fr) Agent anti-ovulatoire de contraception hormonale
CA2350659A1 (fr) Composition pharmaceutique de sensibilisateur modifiant la liberation d'insuline
CA2347750A1 (fr) Composition pharmaceutique contenant de la decursine
JO2213B1 (en) A pharmaceutical composition for use as a contraceptive method
CA2248841A1 (fr) Combinaison sequentielle oestrogene/antagoniste de la progesterone s'utilisant en therapie hormonale de substitution
SI1848406T1 (sl) Trdna peroralna farmacevtska oblika za kontracepcijo, ki vsebuje dienogest in etinilestradiol
NO20072687L (no) Farmasoytisk prevensjonspreparat
TW200638951A (en) Solid oral pharmaceutical form for contraception
ECSP003721A (es) Una composicion farmaceutica para ser usada como anticonceptivo
EP2305267A3 (fr) Combinaison pharmaceutique de l'éthinylestradiol et de la drospirénone pour utilisation comme contraceptif
AU6194100A (en) An oral composition having as a first active ingredient budesonide and as a second active ingredient an antibiotic, for use in intestinal conditions, especiallycrohn's disease
AU6194300A (en) An oral composition having as a first active ingredient rofleponide and as a second active ingredient an antibiotic, for use in intestinal conditions, especially crohn's disease
TH80557A (th) ผลิตภัณฑ์ทางเภสัชกรรมสำหรับการคุมกำเนิดทางช่องปาก

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20200831